talazoparib,enzalutamide
pfizer,astellas
['talzenna', 'talapro-2', 'prostate', 'talapro,2', 'xtandi']
less than 20% of side effects from talzenna plus xtandi were severe, according to data from the talapro-2 trial that tested the drug combo in patients with metastatic castration-resistant prostate cancer. #asco23 #prostatecancer 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.